SAN DIEGO, July 07, 2021 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that it will provide a corporate update and participate in one-on-one investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference, to be… Continue reading Reneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
